SYROS PHARMACEUTICALS INC's ticker is SYRS and the CUSIP is 87184Q107. A total of 73 filers reported holding SYROS PHARMACEUTICALS INC in Q4 2019. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2021 | $174,000 | -17.9% | 38,912 | 0.0% | 0.00% | 0.0% |
Q2 2021 | $212,000 | -86.6% | 38,912 | -81.7% | 0.00% | -86.4% |
Q1 2021 | $1,588,000 | -31.0% | 212,291 | 0.0% | 0.02% | -21.4% |
Q4 2020 | $2,303,000 | +22.7% | 212,291 | 0.0% | 0.03% | -17.6% |
Q3 2020 | $1,877,000 | -17.1% | 212,291 | 0.0% | 0.03% | -19.0% |
Q2 2020 | $2,263,000 | +79.7% | 212,291 | 0.0% | 0.04% | +20.0% |
Q1 2020 | $1,259,000 | -14.2% | 212,291 | 0.0% | 0.04% | 0.0% |
Q4 2019 | $1,467,000 | -96.4% | 212,291 | -94.5% | 0.04% | -97.4% |
Q3 2019 | $40,365,000 | +20.4% | 3,888,752 | +7.4% | 1.35% | +42.4% |
Q2 2019 | $33,525,000 | +123.0% | 3,620,376 | +120.1% | 0.95% | +115.7% |
Q1 2019 | $15,037,000 | +63.7% | 1,645,200 | -0.3% | 0.44% | +18.9% |
Q4 2018 | $9,188,000 | -53.4% | 1,649,538 | -0.4% | 0.37% | -39.0% |
Q3 2018 | $19,725,000 | +18.4% | 1,656,138 | +1.5% | 0.61% | +7.2% |
Q2 2018 | $16,655,000 | -22.3% | 1,631,237 | -1.3% | 0.57% | -31.6% |
Q1 2018 | $21,446,000 | +245.9% | 1,652,240 | +159.3% | 0.83% | +206.7% |
Q4 2017 | $6,200,000 | -34.3% | 637,232 | -0.7% | 0.27% | -42.1% |
Q3 2017 | $9,442,000 | -39.7% | 641,419 | -34.1% | 0.47% | -51.1% |
Q2 2017 | $15,660,000 | +3.2% | 973,260 | +2.2% | 0.95% | -3.2% |
Q1 2017 | $15,177,000 | +31.6% | 952,740 | +0.5% | 0.98% | -0.9% |
Q4 2016 | $11,533,000 | -1.7% | 948,440 | +6.2% | 0.99% | +6.5% |
Q3 2016 | $11,736,000 | -22.1% | 892,782 | -5.6% | 0.93% | -35.1% |
Q2 2016 | $15,058,000 | – | 946,182 | – | 1.44% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Samsara BioCapital, LLC | 881,450 | $5,677,000 | 1.32% |
IFP Advisors, Inc | 50 | $1,000 | 0.00% |
Ten Capital Wealth Advisors, LLC | 219 | $1,000 | 0.00% |